Patient-derived organoid analysis of drug resistance in precision medicine: is there a value?

References

• Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015 Mar 1;136(5):E359–86. PubMed PMID: 25220842.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019 Jan;69(1):7–34. PubMed PMID: 30620402; eng. .
   PubMed Web of Science ®Google Scholar
• Breitenbach M, Hoffmann J. Editorial: cancer models. Front Oncol. 2018;8:401. PubMed PMID: 30338241; PubMed Central PMCID: PMCPMC6178941. eng. .
   PubMed Web of Science ®Google Scholar
• Wyld L, Audisio RA, Poston GJ. The evolution of cancer surgery and future perspectives [Perspective]. Nat Rev Clin Oncol. 2015 Feb;12(2):115–124. PubMed PMID: 25384943. .
   PubMed Web of Science ®Google Scholar
• Chabner BA, Roberts TG Jr. Timeline: chemotherapy and the war on cancer. Nat Rev Cancer. 2005 Jan;5(1):65–72. PubMed PMID: 15630416. .
   PubMed Web of Science ®Google Scholar
• Thariat J, Hannoun-Levi JM, Sun Myint A, et al. Past, present, and future of radiotherapy for the benefit of patients. Nat Rev Clin Oncol. 2013 Jan;10(1):52–60. PubMed PMID: 23183635.
   PubMed Web of Science ®Google Scholar
• Khalil DN, Smith EL, Brentjens RJ, et al. The future of cancer treatment: immunomodulation, CARs and combination immunotherapy [Review Article]. Nat Rev Clin Oncol. 2016 May;13(5):273–290. PubMed PMID: 26977780; PubMed Central PMCID: PMCPMC5551685.
   PubMed Web of Science ®Google Scholar
• Nagle PW, Plukker JTM, Muijs CT, et al. Patient-derived tumor organoids for prediction of cancer treatment response. Semin Cancer Biol. 2018 Dec;53:258–264. PubMed PMID: 29966678; eng.
   PubMed Web of Science ®Google Scholar
• Bahmad H, Hadadeh O, Chamaa F, et al. Modeling human neurological and neurodegenerative diseases: from induced pluripotent stem cells to neuronal differentiation and its applications in neurotrauma. Front Mol Neurosci. 2017;10:50. . PubMed PMID: 28293168; PubMed Central PMCID: PMCPMC5329035. eng.
   PubMed Web of Science ®Google Scholar
• Bahmad HF, Cheaito K, Chalhoub RM, et al. Sphere-formation assay: three-dimensional in vitro culturing of prostate cancer stem/progenitor sphere-forming cells. Front Oncol. 2018;8:347. . PubMed PMID: 30211124; PubMed Central PMCID: PMCPMC6121836. eng.
   PubMed Web of Science ®Google Scholar
• Forsythe S, Pu T, Skardal A. Using organoid models to predict chemotherapy efficacy: the future of precision oncology? Expert Rev Precis Med Drug Dev. 2019 Nov Feb;4(6):317–336. .
   Web of Science ®Google Scholar
• Clarke MF, Dick JE, Dirks PB, et al. Cancer stem cells–perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res. 2006 Oct 1;66(19):9339–9344. PubMed PMID: 16990346; eng.
   PubMedGoogle Scholar
• Bellmunt J. Stem-like signature predicting disease progression in early stage bladder cancer. The role of E2F3 and SOX4. Biomedicines. 2018 Aug 2;6(3):85. PubMed PMID: 30072631; PubMed Central PMCID: PMCPMC6164884. eng. .
   PubMed Web of Science ®Google Scholar
• Elbadawy M, Usui T, Yamawaki H, et al. Development of an experimental model for analyzing drug resistance in colorectal cancer. Cancers (Basel). 2018;10(6):6.PubMed PMID: 29843359; PubMed Central PMCID: PMC6025190. eng.
   Web of Science ®Google Scholar
• Usui T, Sakurai M, Nishikawa S, et al. Establishment of a dog primary prostate cancer organoid using the urine cancer stem cells. Cancer Sci. 2017 Dec;108(12):2383–2392. PubMed PMID: 29024204; PubMed Central PMCID: PMCPMC5715251. eng.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wang Z, Yu J, et al. Cancer stem-like cells contribute to cisplatin resistance and progression in bladder cancer. Cancer Lett. 2012 Sep 1;322(1):70–77. PubMed PMID: 22343321; eng.
   PubMed Web of Science ®Google Scholar
• Bahmad HF, Mouhieddine TH, Chalhoub RM, et al. The Akt/mTOR pathway in cancer stem/progenitor cells is a potential therapeutic target for glioblastoma and neuroblastoma. Oncotarget. 2018 Sep 11;9(71):33549–33561. PubMed PMID: 30323898; PubMed Central PMCID: PMCPMC6173359. eng.
   PubMedGoogle Scholar
• Bahmad HF, Chamaa F, Assi S, et al. Cancer stem cells in neuroblastoma: expanding the therapeutic Frontier. Front Mol Neurosci. 2019;12:131. . PubMed PMID: 31191243; PubMed Central PMCID: PMCPMC6546065. eng.
   PubMed Web of Science ®Google Scholar
• Tsai YC, Chen WY, Abou-Kheir W, et al. Androgen deprivation therapy-induced epithelial-mesenchymal transition of prostate cancer through downregulating SPDEF and activating CCL2. Biochimica Et Biophysica Acta Mol Basis Dis. 2018 May;1864(5 Pt A):1717–1727. PubMed PMID: 29477409; eng.
   PubMed Web of Science ®Google Scholar
• Elbadawy M, Usui T, Yamawaki H, et al. Emerging roles of C-Myc in cancer stem cell-related signaling and resistance to cancer chemotherapy: a potential therapeutic target against colorectal cancer. Int J Mol Sci. 2019 May 11;20(9):2340. PubMed PMID: 31083525; PubMed Central PMCID: PMCPMC6539579. eng.
   PubMed Web of Science ®Google Scholar
• Usui T, Sakurai M, Umata K, et al. Hedgehog signals mediate anti-cancer drug resistance in three-dimensional primary colorectal cancer organoid culture. Int J Mol Sci. 2018 Apr 6;19(4):1098. PubMed PMID: 29642386; PubMed Central PMCID: PMCPMC5979580. eng.
   Web of Science ®Google Scholar
• Elbadawy M, Usui T, Yamawaki H, et al. Novel functions of death-associated protein kinases through mitogen-activated protein kinase-related signals. Int J Mol Sci. 2018 Oct 4;19(10):3031. PubMed PMID: 30287790; PubMed Central PMCID: PMCPMC6213522. eng.
   Web of Science ®Google Scholar
• Lancaster MA, Knoblich JA. Organogenesis in a dish: modeling development and disease using organoid technologies. Science (New York, NY). 2014 Jul 18;345(6194):1247125. PubMed PMID: 25035496; eng. .
   Google Scholar
• Shamir ER, Ewald AJ. Three-dimensional organotypic culture: experimental models of mammalian biology and disease. Nat Rev Mol Cell Biol. 2014 Oct;15(10):647–664. PubMed PMID: 25237826; PubMed Central PMCID: PMCPMC4352326. eng. .
   PubMed Web of Science ®Google Scholar
• Sato T, Vries RG, Snippert HJ, et al. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature. 2009 May 14;459(7244):262–265. PubMed PMID: 19329995; eng.
   PubMed Web of Science ®Google Scholar
• Dutta D, Heo I, Clevers H. disease modeling in stem cell-derived 3D organoid systems. Trends Mol Med. 2017 May;23(5):393–410. PubMed PMID: 28341301. .
   PubMed Web of Science ®Google Scholar
• Elbadawy M, Usui T, Mori T, et al. Establishment of a novel experimental model for muscle-invasive bladder cancer using a dog bladder cancer organoid culture. Cancer Sci. 2019 Sep;110(9):2806–2821. PubMed PMID: 31254429; PubMed Central PMCID: PMCPMC6726682. eng.
   PubMed Web of Science ®Google Scholar
• Baker LA, Tiriac H, Clevers H, et al. Modeling pancreatic cancer with organoids. Trends Cancer. 2016 Apr;2(4):176–190. PubMed PMID: 27135056; PubMed Central PMCID: PMCPMC4847151. eng.
   PubMed Web of Science ®Google Scholar
• Clevers H. Modeling development and disease with organoids. Cell. 2016 Jun 16;165(7):1586–1597. PubMed PMID: 27315476; eng. .
   PubMed Web of Science ®Google Scholar
• Jin MZ, Han RR, Qiu GZ, et al. Organoids: an intermediate modeling platform in precision oncology. Cancer Lett. 2018 Feb;1(414):174–180. . PubMed PMID: 29174804; eng.
   PubMed Web of Science ®Google Scholar
• Bartfeld S, Clevers H. Stem cell-derived organoids and their application for medical research and patient treatment. J Mol Med (Berl). 2017 Jul;95(7):729–738. PubMed PMID: 28391362; eng. .
   PubMed Web of Science ®Google Scholar
• Takahashi T. Organoids for drug discovery and personalized medicine. Annu Rev Pharmacol Toxicol. 2019 Jan 6;59(1):447–462. PubMed PMID: 30113875; eng. .
   PubMedGoogle Scholar
• Usui T, Sakurai M, Enjoji S, et al. Establishment of a novel model for anticancer drug resistance in three-dimensional primary culture of tumor microenvironment. Stem Cells Int. 2016;2016:7053872. . PubMed PMID: 28119740; PubMed Central PMCID: PMCPMC5227181.
   PubMedGoogle Scholar
• van de Wetering M, Francies HE, Francis JM, et al. Prospective derivation of a living organoid biobank of colorectal cancer patients. Cell. 2015 May 7;161(4):933–945. PubMed PMID: 25957691; PubMed Central PMCID: PMCPMC6428276.
   PubMed Web of Science ®Google Scholar
• Di Nicolantonio F, Martini M, Molinari F, et al. Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer. J Clin Oncol. 2008 Dec 10;26(35):5705–5712. PubMed PMID: 19001320; eng.
   PubMed Web of Science ®Google Scholar
• Buzzelli JN, Ouaret D, Brown G, et al. Colorectal cancer liver metastases organoids retain characteristics of original tumor and acquire chemotherapy resistance. Stem Cell Res. 2018 Mar;27:109–120. PubMed PMID: 29414601; PubMed Central PMCID: PMCPMC5842239. eng.
   PubMed Web of Science ®Google Scholar
• Bodgi L, Bahmad HF, Araji T, et al. Assessing radiosensitivity of bladder cancer in vitro: A 2D vs. 3D approach. Front Oncol. 2019;9:153. . PubMed PMID: 30941305; PubMed Central PMCID: PMCPMC6433750. eng.
   PubMed Web of Science ®Google Scholar
• Breslin S, O’Driscoll L. Three-dimensional cell culture: the missing link in drug discovery. Drug Discov Today. 2013 Mar 01;18(5):240–249.
   PubMed Web of Science ®Google Scholar
• Mullenders J, de Jongh E, Brousali A, et al. Mouse and human urothelial cancer organoids: A tool for bladder cancer research. Proc Natl Acad Sci U S A. 2019 Mar 5;116(10):4567–4574. PubMed PMID: 30787188; PubMed Central PMCID: PMCPMC6410883.
   PubMed Web of Science ®Google Scholar
• Choi SI, Jeon AR, Kim MK, et al. Development of patient-derived preclinical platform for metastatic pancreatic cancer: PDOX and a subsequent organoid model system using percutaneous biopsy samples [original research]. Front Oncol. 2019 Sept 13;9(875):875. PubMed PMID: 31572675; PubMed Central PMCID: PMCPMC6753223. English.
   PubMedGoogle Scholar
• Kijima T, Nakagawa H, Shimonosono M, et al. Three-dimensional organoids reveal therapy resistance of esophageal and oropharyngeal squamous cell carcinoma cells. Cell Mol Gastroenterol Hepatol. 2019;7(1):73–91. . PubMed PMID: 30510992; PubMed Central PMCID: PMCPMC6260338. eng.
   PubMed Web of Science ®Google Scholar
• Saito Y, Muramatsu T, Kanai Y, et al. Establishment of patient-derived organoids and drug screening for biliary tract carcinoma. Cell Rep. 2019 Apr 23;27(4):1265–1276 e4. PubMed PMID: 31018139; eng.
   PubMed Web of Science ®Google Scholar
• Li L, Knutsdottir H, Hui K, et al. Human primary liver cancer organoids reveal intratumor and interpatient drug response heterogeneity. JCI Insight. 2019 Jan 24;4(2). PubMed PMID: 30674722; PubMed Central PMCID: PMCPMC6413833. DOI:10.1172/jci.insight.121490.
   Web of Science ®Google Scholar
• Seidlitz T, Merker SR, Rothe A, et al. Human gastric cancer modelling using organoids. Gut. 2019 Feb;68(2):207–217. PubMed PMID: 29703791; PubMed Central PMCID: PMCPMC6352409.
   PubMed Web of Science ®Google Scholar
• Schutte M, Risch T, Abdavi-Azar N, et al. Molecular dissection of colorectal cancer in pre-clinical models identifies biomarkers predicting sensitivity to EGFR inhibitors. Nat Commun. 2017 Feb 10;8(1):14262. PubMed PMID: 28186126; PubMed Central PMCID: PMCPMC5309787. eng.
   PubMedGoogle Scholar
• Tashiro T, Okuyama H, Endo H, et al. In vivo and ex vivo cetuximab sensitivity assay using three-dimensional primary culture system to stratify KRAS mutant colorectal cancer. PloS One. 2017;12(3):e0174151. . PubMed PMID: 28301591; PubMed Central PMCID: PMCPMC5354432. eng.
   PubMed Web of Science ®Google Scholar
• Kondo J, Ekawa T, Endo H, et al. High-throughput screening in colorectal cancer tissue-originated spheroids. Cancer Sci. 2019 Jan;110(1):345–355. PubMed PMID: 30343529; PubMed Central PMCID: PMCPMC6317944. eng.
   PubMed Web of Science ®Google Scholar
• Lee SH, Hu W, Matulay JT, et al. Tumor evolution and drug response in patient-derived organoid models of bladder cancer. Cell. 2018 Apr 5;173(2):515–528 e17. PubMed PMID: 29625057; PubMed Central PMCID: PMCPMC5890941. eng.
   PubMed Web of Science ®Google Scholar
• Yan HHN, Siu HC, Law S, et al. A comprehensive human gastric cancer organoid biobank captures tumor subtype heterogeneity and enables therapeutic screening. Cell Stem Cell. 2018 Dec 6;23(6):882–897 e11. PubMed PMID: 30344100; eng.
   PubMed Web of Science ®Google Scholar
• Pauli C, Hopkins BD, Prandi D, et al. Personalized in vitro and in vivo cancer models to guide precision medicine. Cancer Discov. 2017 May;7(5):462–477. PubMed PMID: 28331002; PubMed Central PMCID: PMCPMC5413423. eng.
   PubMed Web of Science ®Google Scholar